MUC3A promotes the progression of cholangiocarcinoma through the MAPK/ERK pathway
Abstract Aim Cholangiocarcinoma (CCA) is the most common malignant tumor of the bile ducts. Due to its anatomical location, growth pattern, and lack of clear diagnostic criteria, it presents diagnostic challenges. Exploring its occurrence and development to find early markers and treatment targets i...
Saved in:
| Main Authors: | Baijie Feng, Wei Su, Lina Hu, Minghua Yu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-04-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02199-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cystatin B Promotes the Proliferation, Migration, and Invasion of Intrahepatic Cholangiocarcinoma
by: Dai Zhang, et al.
Published: (2025-01-01) -
PGRP-S promotes hepatocellular carcinoma progression via MAPK/ERK pathway by interaction with TTC1
by: Huifang Zhu, et al.
Published: (2025-08-01) -
The effect of 8 weeks of quercetin supplementation and intermittent exercise on gene expression of Muc5Ac, Muc4 and polyphosphate in rats with colon cancer
by: Shahin Heydari, et al.
Published: (2023-01-01) -
Gramicidin inhibits cholangiocarcinoma cell growth by suppressing EGR4
by: Xiaoli Gong, et al.
Published: (2020-01-01) -
MAPK/ERK signaling pathway in rheumatoid arthritis: mechanisms and therapeutic potential
by: Jun Xie, et al.
Published: (2025-07-01)